You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Secondary hemophagocytic lymphohistiocytosis

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Secondary Hemophagocytic Lymphohistiocytosis (sHLH) Trial in Worldwide (ELA026)

Recruiting
  • Secondary Hemophagocytic Lymphohistiocytosis (sHLH)
  • Innsbruck, Austria
  • +9 more
Oct 24, 2022

Immune Function and PD-1 Antibody Therapy Efficacy Predictors on

Recruiting
  • Secondary Hemophagocytic Lymphohistiocytosis
  • Chronic Active Epstein-Barr Virus Infection
  • No intervention
  • Beijing, Beijing, China
    Beijing Friendship Hospital, Capital Medical University
May 2, 2023

Secondary Hemophagocytic Lymphohistiocytosis, Chronic Active Epstein-Barr Virus Infection Trial in Beijing (Rituximab

Recruiting
  • Secondary Hemophagocytic Lymphohistiocytosis
  • Chronic Active Epstein-Barr Virus Infection
  • Rituximab Monotherapy
  • Beijing, China
    Zhao Wang
May 18, 2022

Lymphoma-associated Hemophagocytic Lymphohistiocytosis

Recruiting
  • Lymphoma
  • Hemophagocytic Lymphohistiocytoses
    • Birmingham, Alabama
      University of Alabama at Birmingham
    Jun 1, 2023

    Macrophage Activation Syndrome, Lymphohistiocytosis, Hemophagocytic, Arthritis, Juvenile Trial in Worldwide (Emapalumab)

    Completed
    Has Results
    • Macrophage Activation Syndrome
    • +3 more
    • Cincinnati, Ohio
    • +4 more
    May 16, 2022

    Hemophagocytic Lymphohistiocytoses Trial in Cincinnati

    Recruiting
    • Hemophagocytic Lymphohistiocytoses
      • Cincinnati, Ohio
        Cincinnati Children's Hospital Medical Center
      Oct 25, 2022

      EBV-associated Hemophagocytic Lymphohistiocytosis, EBV Infection Trial in Beijing (EBV-TCR-T cells)

      Recruiting
      • EBV-associated Hemophagocytic Lymphohistiocytosis
      • EBV Infection
      • EBV-TCR-T cells
      • Beijing, Beijing, China
        Chinese PLA General Hospital
      Nov 12, 2023

      Refractory, Recurrence, Hemophagocytic Lymphohistiocytosis Trial (GTP regimen)

      Not yet recruiting
      • Refractory
      • +2 more
      • GTP regimen
      • (no location specified)
      Sep 8, 2023

      Carbapenem Resistant Bacterial Infection, Hemophagocytic Lymphohistiocytoses Trial in Beijing (Carrimycin tablets)

      Not yet recruiting
      • Carbapenem Resistant Bacterial Infection
      • Hemophagocytic Lymphohistiocytoses
      • Carrimycin tablets
      • Beijing, Beijing, China
        Beijing Friendship Hospital, Capital Medical University
      Aug 4, 2023

      IFN? and Inflammatory Mediators in Hemophagocytic

      Completed
      • Hemophagocytic Lymphohistiocytoses
      • Blood Draws Data Collection
      • Boston, Massachusetts
        Brigham and Women's Hospital
      Sep 14, 2023

      Macrophage Activation Syndrome, Secondary Hemophagocytic Lymphohistiocytosis, Still Disease Trial in Worldwide (Emapalumab)

      Recruiting
      • Macrophage Activation Syndrome
      • +6 more
      • Birmingham, Alabama
      • +41 more
      Jan 3, 2023

      Hemophagocytic Syndrome (HPS) Trial in Ann Arbor (Ruxolitinib)

      Completed
      Has Results
      • Hemophagocytic Syndrome (HPS)
      • Ann Arbor, Michigan
        University of Michigan Comprehensive Cancer Center
      Jan 4, 2021

      Hemophagocytic Lymphohistiocytosis Trial in United States (Ruxolitinib, Dexamethasone, Etoposide)

      Recruiting
      • Hemophagocytic Lymphohistiocytosis
      • Phoenix, Arizona
      • +9 more
      Jan 9, 2023

      PD-1 Antibody, Hemophagocytic Lymphohistiocytosis, Epstein-Barr Virus Trial in Beijing (L-DEP and PD-1 antibody)

      Not yet recruiting
      • PD-1 Antibody
      • +3 more
      • L-DEP and PD-1 antibody
      • Beijing, Beijing, China
        Beijing Friendship Hospital, Capital Medical University
      Mar 8, 2023

      Hemophagocytic Lymphohistiocytosis Trial in Philadelphia (tocilizumab)

      Withdrawn
      • Hemophagocytic Lymphohistiocytosis
      • Philadelphia, Pennsylvania
        Children's Hospital of Philadelphia
      Mar 11, 2022

      Hemophagocytic Lymphohistiocytosis Trial in Beijing (Venetoclax, Dexamethasone, Etoposide)

      Recruiting
      • Hemophagocytic Lymphohistiocytosis
      • Beijing, Beijing, China
        Beijing Friendship Hospital, Capital Medical University
      Sep 15, 2022

      Haemophagocytic Lymphohistiocytosis Trial (Ruxolitinib)

      Not yet recruiting
      • Haemophagocytic Lymphohistiocytosis
      • (no location specified)
      Feb 28, 2023

      Hemophagocytic Lymphohistiocytoses, EBV, Metabonomics Trial in Beijing (observational)

      Not yet recruiting
      • Hemophagocytic Lymphohistiocytoses
      • +2 more
      • observational
      • Beijing, Beijing, China
        Beijing Friendship Hospital, Capital Medical University
      Dec 22, 2022

      Prospective Validation of the OHI Index

      Recruiting
      • HLH
      • +4 more
        • Kfar Saba, Israel
        • +1 more
        May 21, 2023

        Hemophagocytic Lymphohistiocytosis Trial in Beijing (L-DEP and PD-1 antibody)

        Not yet recruiting
        • Hemophagocytic Lymphohistiocytosis
        • L-DEP and PD-1 antibody
        • Beijing, China
          Beijing Friendship Hospital, Capital Medical University
        Apr 19, 2022

        Hemophagocytic Syndrome Trial in Chongqing (cyclophosphamide, VP-16, Dexamethasone)

        Recruiting
        • Hemophagocytic Syndrome
        • Chongqing, China
          The Second affiliated Hosptial of Chongqing medical University
        Jun 28, 2023

        Segmental Resection Combined With DEP Regimen for EBV-HLH

        Not yet recruiting
        • Hemophagocytic Lymphohistiocytosis
        • +2 more
        • Segmental bowel resection combined with the DEP regimen
        • Beijing, Beijing, China
          Zhao Wang
        Nov 9, 2023

        Hemophagocytic Lymphohistiocytosis Trial in Beijing (DEP combine with PD-1 antibody)

        Recruiting
        • Hemophagocytic Lymphohistiocytosis
        • DEP combine with PD-1 antibody
        • Beijing, China
          Beijing Friendship Hospital, Capital Medical University
        Feb 13, 2022

        Hemophagocytic Lymphohistiocytoses, Lymphoma Trial in Beijing (cytokine)

        Not yet recruiting
        • Hemophagocytic Lymphohistiocytoses
        • Lymphoma
        • cytokine
        • Beijing, Beijing, China
          Zhao Wang
        Oct 27, 2022

        Assessing the Presence of CT-DNA in Lymphoma Associated HLH

        Not yet recruiting
        • Lymphoma
        • Haemophagocytic Lymphohistiocytosis
          • (no location specified)
          Jan 25, 2023